Neuphoria Therapeutics (NEUP) Accounts Payables (2020 - 2026)
Neuphoria Therapeutics (NEUP) posted Accounts Payables of $385,584 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 66.6% from $1.15 million a year earlier and down 38.5% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Accounts Payables (2020 - 2026) Analysis & Trends
Since fiscal Q4 2020, Neuphoria Therapeutics has reported Accounts Payables for 13 quarters.
- Annual Accounts Payables shows a five-year compound annual growth rate of -22.7% (FY2021 to FY2026).
- In prior fiscal years, Neuphoria Therapeutics' Accounts Payables was $1.15 million in FY2025 (-48.5%), $2.24 million in FY2024 (+55.9%), $1.44 million in FY2023 (-27.9%) and $2 million in FY2022 (+42.8%).
- The fiscal Q4 2026 figure stands as the lowest quarterly Accounts Payables in data going back to fiscal Q4 2020.
- On a year-over-year basis, Accounts Payables has declined in each of the last three quarters, with an average decline of 38.7% over the last five quarters.
- The strongest year-over-year quarter for Accounts Payables in the past five years was fiscal Q4 2022, with growth of 42.8%; the weakest was fiscal Q4 2026, with a decline of 66.6%.
- According to Business Quant data, Accounts Payables for the three prior fiscal quarters was $627,185 (Q3 2026), $520,709 (Q2 2026) and $1.37 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Neuphoria Therapeutics | 443.79 Mn | 368.60 Mn | - | 385,584.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 385,584.00 |
| Mar 31, 2026 | 627,185.00 |
| Dec 31, 2025 | 520,709.00 |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 745,336.00 |
| Dec 31, 2024 | 1.53 Mn |
| Sep 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 2.24 Mn |
| Jun 30, 2023 | 2.34 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Jun 30, 2021 | 1.40 Mn |
| Jun 30, 2020 | 1.52 Mn |
API Access
Neuphoria Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();